5′-氯5′-脱氧腺苷
|
C341772-100mg
|
≥97% |
892-48-8 |
100mg
|
¥ 29.9
|
期货,请咨询 |
阿拉丁 |
γ-CEHC
|
C341663-5mg
|
≥95% |
178167-75-4 |
5mg
|
¥ 2139.9
|
现货 |
阿拉丁 |
γ-CEHC
|
C341663-1mg
|
≥95% |
178167-75-4 |
1mg
|
¥ 539.9
|
现货 |
阿拉丁 |
5-氯胞苷
|
C341553-100mg
|
|
25130-29-4 |
100mg
|
¥ 1494.9
|
期货,请咨询 |
阿拉丁 |
7-氯-2-(氯甲基)-4H-吡啶并[1,2-a]嘧啶-4-酮
|
C341521-1g
|
|
162469-87-6 |
1g
|
¥ 589.9
|
期货,请咨询 |
阿拉丁 |
7-氯-2-(氯甲基)-4H-吡啶并[1,2-a]嘧啶-4-酮
|
C341521-250mg
|
|
162469-87-6 |
250mg
|
¥ 218.9
|
期货,请咨询 |
阿拉丁 |
7-氯-5-苯基[1,2,4]三唑并[1,5-a]嘧啶
|
C341520-1g
|
|
28565-43-7 |
1g
|
¥ 2783.9
|
期货,请咨询 |
阿拉丁 |
7-氯-5-苯基[1,2,4]三唑并[1,5-a]嘧啶
|
C341520-250mg
|
|
28565-43-7 |
250mg
|
¥ 1375.9
|
期货,请咨询 |
阿拉丁 |
2-{3-氰基-7-羟基-5-甲基吡唑并[1,5-a]嘧啶-6-基}乙酸
|
C341518-1g
|
|
1118787-65-7 |
1g
|
¥ 2783.9
|
期货,请咨询 |
阿拉丁 |
2-{3-氰基-7-羟基-5-甲基吡唑并[1,5-a]嘧啶-6-基}乙酸
|
C341518-250mg
|
|
1118787-65-7 |
250mg
|
¥ 1375.9
|
期货,请咨询 |
阿拉丁 |
6-氯吲哚-3-乙腈
|
C341478-5g
|
≥98% |
61220-58-4 |
5g
|
¥ 1540.9
|
期货,请咨询 |
阿拉丁 |
6-氯吲哚-3-乙腈
|
C341478-1g
|
≥98% |
61220-58-4 |
1g
|
¥ 613.9
|
期货,请咨询 |
阿拉丁 |
β-氯-L-丙氨酸
|
C341469-5g
|
≥98% |
2731-73-9 |
5g
|
¥ 3822.9
|
现货 |
阿拉丁 |
β-氯-L-丙氨酸
|
C341469-1g
|
≥98% |
2731-73-9 |
1g
|
¥ 779.9
|
现货 |
阿拉丁 |
2-(4-氯苯基)-5,5-二甲基-1-环己烯-1-甲醇
|
C341444-50mg
|
|
1027345-21-6 |
50mg
|
¥ 1953.9
|
期货,请咨询 |
阿拉丁 |
Compound 15e
|
C341431-5mg
|
≥99% |
371943-05-4 |
5mg
|
¥ 1437.9
|
期货,请咨询 |
阿拉丁 |
Compound 15e
|
C341431-1mg
|
≥99% |
371943-05-4 |
1mg
|
¥ 357.9
|
期货,请咨询 |
阿拉丁 |
Calpain Inhibitor XII
|
C341237-5mg
|
≥90% |
181769-57-3 |
5mg
|
¥ 1647.9
|
期货,请咨询 |
阿拉丁 |
Calpain Inhibitor XII
|
C341237-1mg
|
≥90% |
181769-57-3 |
1mg
|
¥ 566.9
|
期货,请咨询 |
阿拉丁 |
CP-55,940
|
C341166-5mg
|
Moligand™, ≥98% |
83002-04-4 |
5mg
|
¥ 4199.9
|
期货,请咨询 |
阿拉丁 |
N-叔丁氧羰基-反-4-氰基-L-脯氨酸
|
C341113-1g
|
≥97% |
273221-94-6 |
1g
|
¥ 4731.9
|
现货 |
阿拉丁 |
N-叔丁氧羰基-反-4-氰基-L-脯氨酸
|
C341113-10mg
|
≥97% |
273221-94-6 |
10mg
|
¥ 647.9
|
现货 |
阿拉丁 |
7-氯-4-羟基-2-苯基-1,8-萘啶
|
C341010-5mg
|
|
286411-09-4 |
5mg
|
¥ 2762.9
|
期货,请咨询 |
阿拉丁 |
Cpp-AAF-多克隆抗体
|
C341004-5mg
|
|
116560-97-5 |
5mg
|
¥ 7183.9
|
期货,请咨询 |
阿拉丁 |